Stock ScreenerStock IdeasTop Stocks To Sell Now
Stocks to Sell Today: Zen Rating of F As Of Thursday, May 14, 2026
F rated (Strong Sell) stocks have averaged an -8.02% annual decline going back to 2003. Even worse is how bad they do during corrections and bear markets. Own them at your own risk.

Market Cap: $30M - $200B
Zen Rating: F
Ticker
Company
Exchange
Industry
Zen Rating
Market Cap
Price
1d %
EBITDA
P/E
D/E
Country
DD Score
MERC
MERCER INTERNATIONAL INC
NASDAQ
Paper & Paper Products
F$54.46M$0.81-7.61%-$273.56M-0.10x-355.61
Canada
MGX
METAGENOMI THERAPEUTICS INC
NASDAQ
Biotechnology
F$51.95M$1.382.22%-$75.42M-0.60x0.43
United States
CNVS
CINEVERSE CORP
NASDAQ
Entertainment
F$50.29M$2.570.00%-$3.34M-4.94x0.80
United States
PETS
PETMED EXPRESS INC
NASDAQ
Pharmaceutical Retailers
F$48.37M$2.261.80%-$49.40M-0.72x1.69
United States
KSCP
KNIGHTSCOPE INC
NASDAQ
Security & Protection Services
F$47.22M$2.901.40%-$31.22M-0.73x0.49
United States
ATOS
ATOSSA THERAPEUTICS INC
NASDAQ
Biotechnology
F$44.43M$5.160.00%-$37.63M-1.13x0.25
United States
FGNX
FG NEXUS INC
NASDAQ
Insurance - Diversified
F$40.82M$6.527.06%-$95.44M-1.55x0.05
United States
SNBR
SLEEP NUMBER CORP
NASDAQ
Furnishings Fixtures & Appliances
F$40.80M$1.77-6.84%-$32.16M-0.23x-2.02
United States
LITS
LITE STRATEGY INC
NASDAQ
Biotechnology
F$40.15M$1.18-5.60%-$60.82M-0.59x0.02
United States
MLCI
MOUNT LOGAN CAPITAL INC
NASDAQ
Asset Management
F$39.97M$3.57-2.99%-$45.54M-0.50x16.60
United States
RNXT
RENOVORX INC
NASDAQ
Biotechnology
F$38.27M$0.85-2.75%-$11.08M-2.65x0.49
United States
AGPU
AXE COMPUTE INC
NASDAQ
Medical Instruments & Supplies
F$35.89M$6.48-2.70%-$232.41M-0.48x0.11
United States
CRVO
CERVOMED INC
NASDAQ
Biotechnology
F$34.44M$3.72-1.33%-$26.97M-1.25x0.26
United States

Upgrade to Premium to View More

Use the proven Zen Ratings quant model to find stocks with high potential to beat the market. Stocks Zen-Rated "A" have beaten the market by +32.52% annually. Learn More

Already have access to Premium? Sign In
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.